Venetoclax –Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

New England Journal of Medicine,Volume 378, Issue 12, Page 1107-1120, March 2018.

Source: New England Journal of Medicine - March 21, 2018 Category: Internal Medicine Source Type: research